Diabetes mellitus: fatores de risco em trabalhadores de enfermagem Diabetes mellitus: factores de riesgo en trabajadores de enfermería Diabetes mellitus: risk factors for nursing workers

OBJETIVOS: Identificar os fatores de risco para o diabetes mellitus tipo 2, entre trabalhadores de enfermagem do Instituto Estadual de Diabetes e Endocrinologia Luiz Capriglione. MÉTODOS: Estudo transversal com aplicação de dois instrumentos de coleta de dados que incluíram questões abertas e fechadas relativas ao estado de saúde e estilo de vida de 100 trabalhadores de enfermagem dessa instituição de saúde. Foram ainda verificados dados de natureza bioquímica e antropométrica. RESULTADOS: Os resultados confirmaram a ocorrência de importantes fatores de risco de natureza reversível, destacando-se o sedentarismo e a obesidade. CONCLUSÃO: Considera-se a importância do desenvolvimento de ações visando a promoção da saúde com enfoque na prevenção de doenças crônicas, a serem realizadas no próprio ambiente de trabalho.<br>OBJETIVOS: Identificar los factores de riesgo para la diabetes mellitus tipo 2 entre trabajadores de enfermería del Instituto Estatal de Diabetes e Endocrinología Luiz Capriglione. MÉTODOS: Se trata de un estudio transversal con aplicación de dos instrumentos de recolección de datos que incluyeron preguntas abiertas y cerradas relacionadas al estado de salud y estilo de vida de 100 trabajadores de enfermería de esa institución de salud. Fueron también verificados datos de naturaleza bioquímica y antropométrica. RESULTADOS: Los resultados confirmaron la ocurrencia de importantes factores de riesgo de naturaleza reversible, destacándose el sedentarismo y la obesidad. CONCLUSIÓN: Se considera importante desarrollar acciones que tengan por objetivo la promoción de la salude con enfoque en la prevención de enfermedades crónicas, a ser realizadas en el propio ambiente de trabajo.<br>OBJECTIVES: To identify risk factors for type 2 diabetes mellitus, among nursing workers at the State Institute of Diabetes and Endocrinology Luiz Capriglione. METHODS: This is a cross-sectional study in which were applied two data collection instruments that included open and closed questions related to the health status and lifestyle of 100 nursing staff of the health institution. Also the biochemical and anthropometric nature of data were verified. RESULTS: The results confirmed the occurrence of reversible major risk factors, emphasizing physical inactivity and obesity. CONCLUSION: Developing actions aimed at promoting health is considered important, focusing on prevention of chronic diseases and conducted in their own work environment

Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects.

BACKGROUND: The long-term effects of sibutramine treatment on the rates of cardiovascular events and cardiovascular death among subjects at high cardiovascular risk have not been established. METHODS: We enrolled in our study 10,744 overweight or obese subjects, 55 years of age or older, with preexisting cardiovascular disease, type 2 diabetes mellitus, or both to assess the cardiovascular consequences of weight management with and without sibutramine in subjects at high risk for cardiovascular events. All the subjects received sibutramine in addition to participating in a weight-management program during a 6-week, single-blind, lead-in period, after which 9804 subjects underwent random assignment in a double-blind fashion to sibutramine (4906 subjects) or placebo (4898 subjects). The primary end point was the time from randomization to the first occurrence of a primary outcome event (nonfatal myocardial infarction, nonfatal stroke, resuscitation after cardiac arrest, or cardiovascular death). RESULTS: The mean duration of treatment was 3.4 years. The mean weight loss during the lead-in period was 2.6 kg; after randomization, the subjects in the sibutramine group achieved and maintained further weight reduction (mean, 1.7 kg). The mean blood pressure decreased in both groups, with greater reductions in the placebo group than in the sibutramine group (mean difference, 1.2/1.4 mm Hg). The risk of a primary outcome event was 11.4% in the sibutramine group as compared with 10.0% in the placebo group (hazard ratio, 1.16; 95% confidence interval [CI], 1.03 to 1.31; P=0.02). The rates of nonfatal myocardial infarction and nonfatal stroke were 4.1% and 2.6% in the sibutramine group and 3.2% and 1.9% in the placebo group, respectively (hazard ratio for nonfatal myocardial infarction, 1.28; 95% CI, 1.04 to 1.57; P=0.02; hazard ratio for nonfatal stroke, 1.36; 95% CI, 1.04 to 1.77; P=0.03). The rates of cardiovascular death and death from any cause were not increased. CONCLUSIONS: Subjects with preexisting cardiovascular conditions who were receiving long-term sibutramine treatment had an increased risk of nonfatal myocardial infarction and nonfatal stroke but not of cardiovascular death or death from any cause. (Funded by Abbott; ClinicalTrials.gov number, NCT00234832.